Literature DB >> 17689814

ICD-10 adaptations of the Ontario acute myocardial infarction mortality prediction rules performed as well as the original versions.

Marian J Vermeulen1, Jack V Tu, Michael J Schull.   

Abstract

OBJECTIVE: To derive and validate an International Classification of Diseases-10 (ICD-10) version of the Ontario Acute Myocardial Infarction (AMI) mortality prediction rules, used to adjust for case-mix differences in studies of AMI patients using administrative data. STUDY DESIGN AND
SETTING: We linked the records of all Ontario patients admitted with AMI (2002-2004) with mortality data. The original ICD-9 codes were mapped to ICD-10-CA (Canada) codes using both a translation produced by coding experts and a manual search of codes; the final codes were determined by consensus. Comorbidity prevalence and mortality rates were calculated. Multivariable logistic regression models were used to predict 30-day and 1-year mortality and the C-statistic was used to evaluate the discrimination of the models.
RESULTS: We identified 37,271 AMI patients. The most common comorbidities were heart failure and dysrhythmias; 30-day and 1-year mortality rates were 12.3% and 21.8%, respectively; and mortality rates were highest among patients with shock, cancer, and acute renal failure. The C-statistics were 0.77 and 0.80, compared with 0.78 and 0.79 in the ICD-9 version, for 30-day and 1-year mortality, respectively.
CONCLUSION: An ICD-10 version of the AMI mortality prediction rules predicted 30-day and 1-year mortality as well as the original ICD-9 version.

Entities:  

Mesh:

Year:  2007        PMID: 17689814     DOI: 10.1016/j.jclinepi.2006.12.009

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  13 in total

1.  Identifying heart failure using EMR-based algorithms.

Authors:  Geoffrey H Tison; Alanna M Chamberlain; Mark J Pletcher; Shannon M Dunlay; Susan A Weston; Jill M Killian; Jeffrey E Olgin; Véronique L Roger
Journal:  Int J Med Inform       Date:  2018-09-19       Impact factor: 4.046

2.  Use and discontinuation of hormone replacement therapy in women with myocardial infarction: a nationwide study.

Authors:  Ditte-Marie Bretler; Peter Riis Hansen; Steen Zabell Abildstrøm; Casper Haslund Jørgensen; Rikke Sørensen; Morten Lock Hansen; Tina Ken Schramm; Ellen Løkkegaard; Christian Torp-Pedersen; Gunnar Hilmar Gislason
Journal:  Br J Clin Pharmacol       Date:  2011-01       Impact factor: 4.335

3.  Mortality after admission for acute myocardial infarction in Aboriginal and non-Aboriginal people in New South Wales, Australia: a multilevel data linkage study.

Authors:  Deborah A Randall; Louisa R Jorm; Sanja Lujic; Aiden J O'Loughlin; Timothy R Churches; Mary M Haines; Sandra J Eades; Alastair H Leyland
Journal:  BMC Public Health       Date:  2012-04-10       Impact factor: 3.295

4.  Discontinuation of hormone replacement therapy after myocardial infarction and short term risk of adverse cardiovascular events: nationwide cohort study.

Authors:  Ditte-Marie Bretler; Peter Riis Hansen; Rikke Sørensen; Jesper Lindhardsen; Ole Ahlehoff; Charlotte Andersson; Steen Zabell Abildstrøm; Christian Torp-Pedersen; Gunnar Hilmar Gislason
Journal:  BMJ       Date:  2012-03-27

5.  Cardiac medication prescribing and adherence after acute myocardial infarction in Chinese and South Asian Canadian patients.

Authors:  Emily J Lai; Maja Grubisic; Anita Palepu; Hude Quan; Kathryn M King; Nadia A Khan
Journal:  BMC Cardiovasc Disord       Date:  2011-09-18       Impact factor: 2.298

6.  Patterns of health service use in community living older adults with dementia and comorbid conditions: a population-based retrospective cohort study in Ontario, Canada.

Authors:  Lauren E Griffith; Andrea Gruneir; Kathryn Fisher; Dilzayn Panjwani; Sima Gandhi; Li Sheng; Amiram Gafni; Christopher Patterson; Maureen Markle-Reid; Jenny Ploeg
Journal:  BMC Geriatr       Date:  2016-10-26       Impact factor: 3.921

7.  Association of Early-Stage Breast Cancer and Subsequent Chemotherapy With Risk of Atrial Fibrillation.

Authors:  Husam Abdel-Qadir; Paaladinesh Thavendiranathan; Kinwah Fung; Eitan Amir; Peter C Austin; Geoffrey S Anderson; Douglas S Lee
Journal:  JAMA Netw Open       Date:  2019-09-04

8.  Characteristics and Outcomes of Women Developing Heart Failure After Early Stage Breast Cancer Chemotherapy: A Population-Based Matched Cohort Study.

Authors:  Husam Abdel-Qadir; Felicia Tai; Ruth Croxford; Peter C Austin; Eitan Amir; Oscar Calvillo-Argüelles; Heather Ross; Douglas S Lee; Paaladinesh Thavendiranathan
Journal:  Circ Heart Fail       Date:  2021-06-30       Impact factor: 8.790

9.  Prognosis after percutaneous coronary intervention in patients with psoriasis: a cohort study using Danish nationwide registries.

Authors:  Ole Ahlehoff; Jesper Lindhardsen; Gunnar H Gislason; Jonas B Olesen; Mette Charlot; Lone Skov; Christian Torp-Pedersen; Peter R Hansen
Journal:  BMC Cardiovasc Disord       Date:  2012-09-24       Impact factor: 2.298

10.  Hormone replacement therapy and risk of new-onset atrial fibrillation after myocardial infarction--a nationwide cohort study.

Authors:  Ditte-Marie Bretler; Peter Riis Hansen; Jesper Lindhardsen; Ole Ahlehoff; Charlotte Andersson; Thomas Bo Jensen; Jakob Raunsø; Christian Torp-Pedersen; Gunnar Hilmar Gislason
Journal:  PLoS One       Date:  2012-12-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.